about
Treatment of Raynaud phenomenon in systemic sclerosis.Circulating fibroblast activation protein and dipeptidyl peptidase 4 in rheumatoid arthritis and systemic sclerosis.Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort studyComorbidity in psoriatic arthritis and rheumatoid arthritisThe OMERACT Emerging Leaders Program: The Good, the Bad, and the FutureCardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort studyInvestigating Dimensions of Stiffness in Rheumatoid and Psoriatic Arthritis: The Australian Rheumatology Association Database Registry and OMERACT Collaboration
P50
Q38076483-616983D9-4752-4F91-9A20-92C3E868F531Q48141620-89C6DBC1-D25B-4AAD-903D-D10433FE3195Q56243555-A3C39819-9302-44A5-AD4E-EC4A72DE16ADQ90483543-5DA34E85-E82F-43EA-AE62-6FB4D823035EQ92061222-62329AA7-FCF4-4131-BD4B-3B40FD57AFC3Q92464764-D842919E-378A-47EF-85C8-95960F408310Q92766013-FDE49D97-C122-4254-81CC-C3D6F752096A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Premarani Sinnathurai
@ast
Premarani Sinnathurai
@en
Premarani Sinnathurai
@es
Premarani Sinnathurai
@nl
type
label
Premarani Sinnathurai
@ast
Premarani Sinnathurai
@en
Premarani Sinnathurai
@es
Premarani Sinnathurai
@nl
prefLabel
Premarani Sinnathurai
@ast
Premarani Sinnathurai
@en
Premarani Sinnathurai
@es
Premarani Sinnathurai
@nl
P106
P31
P496
0000-0002-8142-1274